Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Safety of Co-Administration Versus Separate Administration of the Same Vaccines in Children: A Systematic Literature Review.

Bauwens J, Saenz LH, Reusser A, Künzli N, Bonhoeffer J.

Vaccines (Basel). 2019 Dec 31;8(1). pii: E12. doi: 10.3390/vaccines8010012. Review.

2.

Arthritis and arthralgia as an adverse event following immunization: A systematic literature review.

Panozzo CA, Pourmalek F, Brauchli Pernus Y, Pileggi GS, Woerner A, Bonhoeffer J; Brighton Collaboration Aseptic Arthritis Working Group.

Vaccine. 2019 Jan 7;37(2):372-383. doi: 10.1016/j.vaccine.2018.06.067. Epub 2018 Nov 28.

PMID:
30502066
3.

Acute aseptic arthritis: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data.

Woerner A, Pourmalek F, Panozzo C, Pileggi G, Hudson M, Caric A, Abraham S, Varricchio F, Velasco C, Oleske J, Bauwens J, Bonhoeffer J; Brighton Collaboration Acute Aseptic Arthritis Working Group.

Vaccine. 2019 Jan 7;37(2):384-391. doi: 10.1016/j.vaccine.2017.08.087. Epub 2018 Oct 17. Review. No abstract available.

PMID:
30342899
4.

Vaccine Update: Recent Progress With Novel Vaccines, and New Approaches to Safety Monitoring and Vaccine Shortage.

Ndaya-Oloo P, Pitisuttithum P, Tornieporth NG, Desgrandchamps D, Munoz FM, Kochhar S, Buttery J, Bauwens J, Bonhoeffer J.

J Clin Pharmacol. 2018 Oct;58 Suppl 10:S123-S139. doi: 10.1002/jcph.1140.

PMID:
30248195
5.

Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment.

Weibel D, Sturkenboom M, Black S, de Ridder M, Dodd C, Bonhoeffer J, Vanrolleghem A, van der Maas N, Lammers GJ, Overeem S, Gentile A, Giglio N, Castellano V, Kwong JC, Murray BJ, Cauch-Dudek K, Juhasz D, Campitelli M, Datta AN, Kallweit U, Huang WT, Huang YS, Hsu CY, Chen HC, Giner-Soriano M, Morros R, Gaig C, Tió E, Perez-Vilar S, Diez-Domingo J, Puertas FJ, Svenson LW, Mahmud SM, Carleton B, Naus M, Arnheim-Dahlström L, Pedersen L, DeStefano F, Shimabukuro TT.

Vaccine. 2018 Oct 1;36(41):6202-6211. doi: 10.1016/j.vaccine.2018.08.008. Epub 2018 Aug 16.

6.

Intussusception in Young Children: Protocol for Multisite Hospital Sentinel Surveillance in India.

Das MK, Arora NK, Bonhoeffer J, Zuber PLF, Maure CG.

Methods Protoc. 2018 Mar 22;1(2). pii: E11. doi: 10.3390/mps1020011.

7.

Cytokine kinetic profiles in children with acute lower respiratory tract infection: a post hoc descriptive analysis from a randomized control trial.

Fuchs A, Gotta V, Decker ML, Szinnai G, Baumann P, Bonhoeffer J, Ritz N; ProPAED study group.

Clin Microbiol Infect. 2018 Dec;24(12):1341.e1-1341.e7. doi: 10.1016/j.cmi.2018.03.016. Epub 2018 Mar 17.

8.

Safety assessment of immunization in pregnancy.

Kochhar S, Bauwens J, Bonhoeffer J; GAIA Project Participants. Electronic address: http://www.gaia-consortium.net/.

Vaccine. 2017 Dec 4;35(48 Pt A):6469-6471. doi: 10.1016/j.vaccine.2017.09.033. Epub 2017 Oct 12. No abstract available.

9.

Drivers of antibiotic prescribing in children and adolescents with febrile lower respiratory tract infections.

Gotta V, Baumann P, Ritz N, Fuchs A, Baer G, Bonhoeffer JM, Heininger U, Szinnai G, Bonhoeffer J; ProPAED study group.

PLoS One. 2017 Sep 28;12(9):e0185197. doi: 10.1371/journal.pone.0185197. eCollection 2017.

10.

Procalcitonin for Diagnostics and Treatment Decisions in Pediatric Lower Respiratory Tract Infections.

Baumann P, Baer G, Bonhoeffer J, Fuchs A, Gotta V, Heininger U, Ritz N, Szinnai G, Bonhoeffer J.

Front Pediatr. 2017 Aug 28;5:183. doi: 10.3389/fped.2017.00183. eCollection 2017.

11.

Acute wheeze in the pediatric population: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.

Katz MA, Marangu D, Attia EF, Bauwens J, Bont LJ, Bulatovic A, Crane J, Doroshenko A, Ebruke BE, Edwards KM, Fortuna L, Jagelaviciene A, Joshi J, Kemp J, Kovacs S, Lambach P, Lewis KDC, Ortiz JR, Simões EAF, Turner P, Tagbo BN, Vaishnavi V, Bonhoeffer J; Brighton Collaboration Wheeze Working Group.

Vaccine. 2019 Jan 7;37(2):392-399. doi: 10.1016/j.vaccine.2017.01.083. Epub 2017 May 5. No abstract available.

12.

Immunization in pregnancy clinical research in low- and middle-income countries - Study design, regulatory and safety considerations.

Kochhar S, Bonhoeffer J, Jones CE, Muñoz FM, Honrado A, Bauwens J, Sobanjo-Ter Meulen A, Hirschfeld S.

Vaccine. 2017 Dec 4;35(48 Pt A):6575-6581. doi: 10.1016/j.vaccine.2017.03.103. Epub 2017 May 4.

13.

Kawasaki disease and immunisation: A systematic review.

Phuong LK, Bonetto C, Buttery J, Pernus YB, Chandler R, Felicetti P, Goldenthal KL, Kucuku M, Monaco G, Pahud B, Shulman ST, Top KA, Trotta F, Ulloa-Gutierrez R, Varricchio F, de Ferranti S, Newburger JW, Dahdah N, Singh S, Bonhoeffer J, Burgner D; Brighton Collaboration Kawasaki Disease (KD) Working Group.

Vaccine. 2017 Mar 27;35(14):1770-1779. doi: 10.1016/j.vaccine.2016.09.033. Epub 2017 Mar 2. Review.

PMID:
28259442
14.

IgA vasculitis (Henoch-Schönlein): Case definition andguidelines for data collection, analysis, and presentation of immunisation safety data.

Woerner A, Rudin C, Bonetto C, Santuccio C, Ozen S, Wise RP, Chandler R, Bonhoeffer J; Brighton Collaboration lgA Vasclitis (Henoch–Schönlein) Working Group.

Vaccine. 2017 Mar 13;35(11):1559-1566. doi: 10.1016/j.vaccine.2016.09.024. Epub 2016 Dec 26. No abstract available.

PMID:
28034474
15.

Single organ cutaneous vasculitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.

Zanoni G, Girolomoni G, Bonetto C, Trotta F, Häusermann P, Opri R, Bonhoeffer J; Brighton Collaboration Single Organ Cutaneous Vasculitis Working Group.

Vaccine. 2016 Dec 12;34(51):6561-6571. doi: 10.1016/j.vaccine.2016.09.032. Epub 2016 Oct 28. Review. No abstract available.

PMID:
28029543
16.

Kawasaki disease and immunisation: Standardised case definition & guidelines for data collection, analysis.

Phuong LK, Bonetto C, Buttery J, Pernus YB, Chandler R, Goldenthal KL, Kucuku M, Monaco G, Pahud B, Shulman ST, Top KA, Ulloa-Gutierrez R, Varricchio F, de Ferranti S, Newburger JW, Dahdah N, Singh S, Bonhoeffer J, Burgner D; Brighton Collaboration Kawasaki Disease (KD) Working Group.

Vaccine. 2016 Dec 12;34(51):6582-6596. doi: 10.1016/j.vaccine.2016.09.025. Epub 2016 Nov 15. Review. No abstract available.

PMID:
27863715
17.

Evaluation of a multinational, multilingual vaccine debate on Twitter.

Becker BF, Larson HJ, Bonhoeffer J, van Mulligen EM, Kors JA, Sturkenboom MC.

Vaccine. 2016 Dec 7;34(50):6166-6171. doi: 10.1016/j.vaccine.2016.11.007. Epub 2016 Nov 10.

PMID:
27840012
18.

Systemic Lupus Erythematosus: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.

Hersh AO, Alarcón GS, Bonetto C, Pernus YB, Kucuku M, Santuccio C, Živković S, Bonhoeffer J; Brighton Collaboration Systemic Lupus Erythematosus Working Group.

Vaccine. 2016 Dec 12;34(51):6572-6581. doi: 10.1016/j.vaccine.2016.09.031. Epub 2016 Nov 2. Review. No abstract available.

PMID:
27816371
19.

Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy.

Jones CE, Munoz FM, Kochhar S, Vergnano S, Cutland CL, Steinhoff M, Black S, Heininger U, Bonhoeffer J, Heath PT.

Vaccine. 2016 Dec 1;34(49):6007-6014. doi: 10.1016/j.vaccine.2016.07.007. Epub 2016 Oct 25.

20.

Global alignment of immunization safety assessment in pregnancy - The GAIA project.

Bonhoeffer J, Kochhar S, Hirschfeld S, Heath PT, Jones CE, Bauwens J, Honrado Á, Heininger U, Muñoz FM, Eckert L, Steinhoff M, Black S, Padula M, Sturkenboom M, Buttery J, Pless R, Zuber P; GAIA project participants.

Vaccine. 2016 Dec 1;34(49):5993-5997. doi: 10.1016/j.vaccine.2016.07.006. Epub 2016 Oct 14.

21.

Obstetrical and neonatal case definitions for immunization safety data.

Chen RT, Moro PL, Bauwens J, Bonhoeffer J.

Vaccine. 2016 Dec 1;34(49):5991-5992. doi: 10.1016/j.vaccine.2016.08.026. Epub 2016 Aug 20. No abstract available.

22.

Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women.

Jones CE, Munoz FM, Spiegel HM, Heininger U, Zuber PL, Edwards KM, Lambach P, Neels P, Kohl KS, Gidudu J, Hirschfeld S, Oleske JM, Khuri-Bulos N, Bauwens J, Eckert LO, Kochhar S, Bonhoeffer J, Heath PT; Brighton Collaboration Immunization in Pregnancy Working Group.

Vaccine. 2016 Dec 1;34(49):5998-6006. doi: 10.1016/j.vaccine.2016.07.032. Epub 2016 Jul 29.

23.

Pandemic influenza vaccine & narcolepsy: simulations on the potential impact of bias.

Wijnans L, Dodd C, de Ridder M, Romio S, Weibel D, Overeem S, Lammers GJ, Bonhoeffer J, Black S, Sturkenboom M.

Expert Rev Vaccines. 2016 May;15(5):573-84. doi: 10.1586/14760584.2016.1164045. Epub 2016 Mar 31.

PMID:
26967200
24.

Vasculitic peripheral neuropathy: Case definition and guidelines for collection, analysis, and presentation of immunisation safety data.

Hadden RDM, Collins MP, Živković SA, Hsieh ST, Bonetto C, Felicetti P, Marchione P, Santuccio C, Bonhoeffer J; Brighton Collaboration Vasculitic Peripheral Neuropathy Working Group.

Vaccine. 2017 Mar 13;35(11):1567-1578. doi: 10.1016/j.vaccine.2015.11.047. Epub 2015 Dec 2. No abstract available.

PMID:
26655629
25.

Global Vaccine Safety Assessment: Challenges and Opportunities.

Tomianovic D, Bauwens J, Heininger U, Bonhoeffer J.

Pediatr Infect Dis J. 2016 Apr;35(4):446-8. doi: 10.1097/INF.0000000000000983. Review. No abstract available.

PMID:
26555389
26.

Factors affecting the causality assessment of adverse events following immunisation in paediatric clinical trials: An online survey.

Voysey M, Tavana R, Farooq Y, Heath PT, Bonhoeffer J, Snape MD.

Vaccine. 2015 Dec 16;33(51):7203-7210. doi: 10.1016/j.vaccine.2015.10.126. Epub 2015 Nov 6.

PMID:
26552002
27.

Reference set for performance testing of pediatric vaccine safety signal detection methods and systems.

Brauchli Pernus Y, Nan C, Verstraeten T, Pedenko M, Osokogu OU, Weibel D, Sturkenboom M, Bonhoeffer J; GRIP consortium.

Vaccine. 2016 Dec 12;34(51):6626-6633. doi: 10.1016/j.vaccine.2015.10.013. Epub 2015 Oct 20.

PMID:
26496461
28.

A systematic review of adverse events following immunization during pregnancy and the newborn period.

Fulton TR, Narayanan D, Bonhoeffer J, Ortiz JR, Lambach P, Omer SB.

Vaccine. 2015 Nov 25;33(47):6453-65. doi: 10.1016/j.vaccine.2015.08.043. Epub 2015 Sep 26. Review.

29.

Vasculitis as an adverse event following immunization - Systematic literature review.

Bonetto C, Trotta F, Felicetti P, Alarcón GS, Santuccio C, Bachtiar NS, Brauchli Pernus Y, Chandler R, Girolomoni G, Hadden RD, Kucuku M, Ozen S, Pahud B, Top K, Varricchio F, Wise RP, Zanoni G, Živković S, Bonhoeffer J; Brighton Collaboration Vasculitis Working Group.

Vaccine. 2016 Dec 12;34(51):6641-6651. doi: 10.1016/j.vaccine.2015.09.026. Epub 2015 Sep 21. Review.

PMID:
26398442
30.

Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases.

Felicetti P, Trotta F, Bonetto C, Santuccio C, Brauchli Pernus Y, Burgner D, Chandler R, Girolomoni G, Hadden RD, Kochhar S, Kucuku M, Monaco G, Ozen S, Pahud B, Phuong L, Bachtiar NS, Teeba A, Top K, Varricchio F, Wise RP, Zanoni G, Živkovic S, Bonhoeffer J; Brighton Collaboration Vasculitis Working Group.

Vaccine. 2016 Dec 12;34(51):6634-6640. doi: 10.1016/j.vaccine.2015.09.027. Epub 2015 Sep 21.

PMID:
26392009
31.

Key terms for the assessment of the safety of vaccines in pregnancy: Results of a global consultative process to initiate harmonization of adverse event definitions.

Munoz FM, Eckert LO, Katz MA, Lambach P, Ortiz JR, Bauwens J, Bonhoeffer J.

Vaccine. 2015 Nov 25;33(47):6441-52. doi: 10.1016/j.vaccine.2015.07.112. Epub 2015 Sep 19. Review.

32.

Wheeze as an adverse event in pediatric vaccine and drug randomized controlled trials: A systematic review.

Marangu D, Kovacs S, Walson J, Bonhoeffer J, Ortiz JR, John-Stewart G, Horne DJ.

Vaccine. 2015 Oct 5;33(41):5333-5341. doi: 10.1016/j.vaccine.2015.08.060. Epub 2015 Aug 28. Review.

33.

Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project.

de Bie S, Ferrajolo C, Straus SM, Verhamme KM, Bonhoeffer J, Wong IC, Sturkenboom MC; GRiP network.

PLoS One. 2015 Jun 19;10(6):e0130399. doi: 10.1371/journal.pone.0130399. eCollection 2015.

34.

Pediatric drug safety signal detection: a new drug-event reference set for performance testing of data-mining methods and systems.

Osokogu OU, Fregonese F, Ferrajolo C, Verhamme K, de Bie S, 't Jong G, Catapano M, Weibel D, Kaguelidou F, Bramer WM, Hsia Y, Wong IC, Gazarian M, Bonhoeffer J, Sturkenboom M.

Drug Saf. 2015 Feb;38(2):207-17. doi: 10.1007/s40264-015-0265-0.

35.

The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level.

Maure CG, Dodoo AN, Bonhoeffer J, Zuber PL.

Bull World Health Organ. 2014 Sep 1;92(9):695-6. doi: 10.2471/BLT.14.138875. Epub 2014 Jul 31. No abstract available.

36.

Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?

Trifirò G, Coloma PM, Rijnbeek PR, Romio S, Mosseveld B, Weibel D, Bonhoeffer J, Schuemie M, van der Lei J, Sturkenboom M.

J Intern Med. 2014 Jun;275(6):551-61. doi: 10.1111/joim.12159. Review.

37.

Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe.

Romio S, Weibel D, Dieleman JP, Olberg HK, de Vries CS, Sammon C, Andrews N, Svanström H, Mølgaard-Nielsen D, Hviid A, Lapeyre-Mestre M, Sommet A, Saussier C, Castot A, Heijbel H, Arnheim-Dahlström L, Sparen P, Mosseveld M, Schuemie M, van der Maas N, Jacobs BC, Leino T, Kilpi T, Storsaeter J, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC.

PLoS One. 2014 Jan 3;9(1):e82222. doi: 10.1371/journal.pone.0082222. eCollection 2014.

38.

Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial.

Baer G, Baumann P, Buettcher M, Heininger U, Berthet G, Schäfer J, Bucher HC, Trachsel D, Schneider J, Gambon M, Reppucci D, Bonhoeffer JM, Stähelin-Massik J, Schuetz P, Mueller B, Szinnai G, Schaad UB, Bonhoeffer J.

PLoS One. 2013 Aug 6;8(8):e68419. doi: 10.1371/journal.pone.0068419. Print 2013.

39.

International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.

Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, Zuber P, Hua W, Bonhoeffer J, Buttery J, Crawford N, Deceuninck G, de Vries C, De Wals P, Gutierrez-Gimeno MV, Heijbel H, Hughes H, Hur K, Hviid A, Kelman J, Kilpi T, Chuang SK, Macartney K, Rett M, Lopez-Callada VR, Salmon D, Gimenez-Sanchez F, Sanz N, Silverman B, Storsaeter J, Thirugnanam U, van der Maas N, Yih K, Zhang T, Izurieta H; Global H1N1 GBS Consortium.

Vaccine. 2013 Sep 13;31(40):4448-58. doi: 10.1016/j.vaccine.2013.06.032. Epub 2013 Jun 14.

PMID:
23770307
40.

Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines.

Izurieta HS, Zuber P, Bonhoeffer J, Chen RT, Sankohg O, Laserson KF, Sturkenboom M, Loucq C, Weibel D, Dodd C, Black S.

Vaccine. 2013 Aug 2;31(35):3623-7. doi: 10.1016/j.vaccine.2013.05.027. Epub 2013 May 21.

PMID:
23707171
41.

Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization.

Amarasinghe A, Black S, Bonhoeffer J, Carvalho SM, Dodoo A, Eskola J, Larson H, Shin S, Olsson S, Balakrishnan MR, Bellah A, Lambach P, Maure C, Wood D, Zuber P, Akanmori B, Bravo P, Pombo M, Langar H, Pfeifer D, Guichard S, Diorditsa S, Hossain MS, Sato Y.

Vaccine. 2013 Apr 18;31 Suppl 2:B108-14. doi: 10.1016/j.vaccine.2012.10.119. Review.

PMID:
23598471
42.

Template protocol for clinical trials investigating vaccines--focus on safety elements.

Bonhoeffer J, Imoukhuede EB, Aldrovandi G, Bachtiar NS, Chan ES, Chang S, Chen RT, Fernandopulle R, Goldenthal KL, Heffelfinger JD, Hossain S, Jevaji I, Khamesipour A, Kochhar S, Makhene M, Malkin E, Nalin D, Prevots R, Ramasamy R, Sellers S, Vekemans J, Walker KB, Wilson P, Wong V, Zaman K, Heininger U; Brighton Collaboration Clinical Trial Protocol Working Group.

Vaccine. 2013 Nov 12;31(47):5602-20. doi: 10.1016/j.vaccine.2013.02.041. Epub 2013 Mar 13.

43.

A systematic review of safety data reporting in clinical trials of vaccines against malaria, tuberculosis, and human immunodeficiency virus.

Tamminga C, Kavanaugh M, Fedders C, Maiolatesi S, Abraham N, Bonhoeffer J, Heininger U, Vasquez CS, Moorthy VS, Epstein JE, Richie TL.

Vaccine. 2013 Aug 2;31(35):3628-35. doi: 10.1016/j.vaccine.2013.01.045. Epub 2013 Feb 8. Review.

PMID:
23395586
44.

Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation.

Poli F, Overeem S, Lammers GJ, Plazzi G, Lecendreux M, Bassetti CL, Dauvilliers Y, Keene D, Khatami R, Li Y, Mayer G, Nohynek H, Pahud B, Paiva T, Partinen M, Scammell TE, Shimabukuro T, Sturkenboom M, van Dinther K, Wiznitzer M, Bonhoeffer J.

Vaccine. 2013 Jan 30;31(6):994-1007. doi: 10.1016/j.vaccine.2012.12.014. Epub 2012 Dec 16. Review. No abstract available.

PMID:
23246545
45.

The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns.

Wijnans L, Lecomte C, de Vries C, Weibel D, Sammon C, Hviid A, Svanström H, Mølgaard-Nielsen D, Heijbel H, Dahlström LA, Hallgren J, Sparen P, Jennum P, Mosseveld M, Schuemie M, van der Maas N, Partinen M, Romio S, Trotta F, Santuccio C, Menna A, Plazzi G, Moghadam KK, Ferro S, Lammers GJ, Overeem S, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC.

Vaccine. 2013 Feb 6;31(8):1246-54. doi: 10.1016/j.vaccine.2012.12.015. Epub 2012 Dec 16.

PMID:
23246544
46.

Current status and future directions of post-marketing vaccine safety monitoring with focus on USA and Europe.

Bonhoeffer J, Black S, Izurieta H, Zuber P, Sturkenboom M.

Biologicals. 2012 Sep;40(5):393-7. doi: 10.1016/j.biologicals.2012.07.007. Epub 2012 Aug 17. Review. Erratum in: Biologicals. 2013 Mar;41(2):128.

PMID:
22902972
47.

Safety of pandemic H1N1 vaccines in children and adolescents.

Wijnans L, de Bie S, Dieleman J, Bonhoeffer J, Sturkenboom M.

Vaccine. 2011 Oct 6;29(43):7559-71. doi: 10.1016/j.vaccine.2011.08.016. Epub 2011 Aug 5. Review.

PMID:
21821086
48.

Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely premature infants.

Schlapbach LJ, Aebischer M, Adams M, Natalucci G, Bonhoeffer J, Latzin P, Nelle M, Bucher HU, Latal B; Swiss Neonatal Network and Follow-Up Group.

Pediatrics. 2011 Aug;128(2):e348-57. doi: 10.1542/peds.2010-3338. Epub 2011 Jul 18.

PMID:
21768312
49.

Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe.

Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, Sturkenboom M; VAESCO-GBS Case-Control Study Group.

BMJ. 2011 Jul 12;343:d3908. doi: 10.1136/bmj.d3908.

50.

A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark.

Andrews N, Stowe J, Miller E, Svanström H, Johansen K, Bonhoeffer J, Hviid A; VAESCO consortium.

Vaccine. 2012 Apr 19;30(19):3042-6. doi: 10.1016/j.vaccine.2011.06.009. Epub 2011 Jun 23.

PMID:
21699947

Supplemental Content

Loading ...
Support Center